For more than a decade, Dana-Farber Cancer Institute has been one of the country’s most prominent recipients of federal research funding. This week, that relationship came under sharp scrutiny.
The U.S. Treasury Department’s Office of Foreign Assets Control (OFAC) has reached a $3.1 million settlement with Exodus Movement, Inc., concluding a multi-year investigation into the crypto wallet provider’s dealings with users in Iran in violation of U.S. sanctions.
This report examines employee perceptions of corporate compliance programs across four countries: the United States, Canada, Germany, and France. Based on survey responses from more than 800 employees across multiple industries, the findings offer a cross-national view of how compliance programs are understood, implemented, and supported, including the growing role of AI.
At the height of the pandemic, the Paycheck Protection Program was meant to act as a financial lifeline for small American businesses struggling through shutdowns and economic uncertainty. Federal prosecutors now say three real estate companies tied to a major Chinese conglomerate should never have qualified for that relief.
The Federal Trade Commission has widened its legal fight with Uber, filing an amended complaint alongside 21 states and the District of Columbia that accuses the company of enrolling consumers in its Uber One subscription without consent, failing to deliver promised savings, and putting up significant barriers for users who try to cancel.
FINRA’s 2026 Annual Regulatory Oversight Report offers a window into how risk is showing up across broker-dealers, drawn directly from the regulator’s examination and enforcement experience. While the report does not introduce new rules, it highlights recurring weaknesses and emerging pressure points, from the use of generative AI to cyber-enabled fraud and small-cap market manipulation, that are expected to shape FINRA’s supervisory focus throughout 2026.
What began as a lucrative wound-care operation in Arizona ultimately collapsed under the weight of its own incentives, leaving behind a trail of vulnerable patients, hollowed-out compliance controls, and more than $1.2 billion in fraudulent health care claims.